Neuroendocrine tumours trials in Denmark
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Copenhagen, Odense C
- Age
- 12 years and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - Phase 3Taking peopleDAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
- Where
- Aarhus N, Copenhagen Oe, Odense C
- Age
- 18 years and over
- People
- 390 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07544654 · EU 2025-523869-22-00 - Phase 3Taking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Herlev
- Age
- 18 years and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00 - Phase 3Taking peopleStudy Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide versus Durvalumab, Carboplatin, and Etoposide in First-Line ES-SCLC (DeLLphi-312)
- Where
- Copenhagen Oe, Herning
- Age
- 18 years and over
- People
- 156 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-520050-38-00 · EU 2024-520050-38-00 - Phase 2Taking peopleDosimetry Based PRRT Versus Standard Dose PRRT With Lu-177-DOTATOC in NEN Patients
- Where
- Aarhus
- Age
- 18 years and over
- People
- 100
- Run by
- Tine Gregersen, MD
See details and how to joinNCT04917484 - Phase 2Taking peopleDosimetry based PRRT versus standard dose PRRT with Lu-177-DOTATOC in NEN patients- a randomized study; a step towards tailored PRRT.
- Where
- Aarhus N
- Age
- 18 years and over
- People
- 100
- Run by
- Region Midtjylland
See details and how to join2024-517240-62-00 · EU 2024-517240-62-00 - No phaseNot yet taking people in DenmarkDevelopment of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study
- Where
- Copenhagen
- Age
- 0 years to 120 years
- People
- 400
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT04788927